Cutting Edge Technologies, Common Sense Solutions

AACC's 2013 webinar series is designed to highlight the areas of laboratory testing where new technologies are making an impact and provide the latest thinking on best practices for the lab in four clinical areas that are experiencing growth. Attend these webinars and learn common sense approaches to incorporating new test technologies from experts in the fields of cancer biomarkers, TDM/toxicology, cardiac and cardiovascular disease, and infectious disease.

The Cutting Edge Technologies series of webinars are available as a 12-pack, as a 3-pack by clinical area, or individually. Discounts are given on the 12-pack and the 3-packs (listed below).

• Cancer 3-pack—January, February and March webinars cover topics related to the use of circulating tumor cells, new test strategies for colorectal cancer screening, and best practices in prostate cancer detection
• TDM/tox 3-pack—April, May and June programs address the lab's role in supporting pain management programs, the advantages and disadvantages of using mass spec versus immunoassay for monitoring the use and effectiveness of immunosuppressant drugs, and testing for new drugs of abuse
• Cardiac/Cardiovascular Disease 3-pack—July, August and September webinars examine testing for lipoproteins, heart failure biomarkers, and whether it's better to have speed or accuracy when using cardiac troponin to assess chest pain patients
• Infectious Disease 3-pack—October, November and December programs focus on molecular methods for diagnosing respiratory viruses, a new biomarker strategy for early diagnosis of sepsis, and how new screening guidelines and new antiviral therapies are changing HCV testing practices